Read + Share
Amedeo Smart
Independent Medical Education
Wang X, Zeng Z, Cai J, Xu P, et al. Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non-small-cell lung cancer: a propensity-matched retrospective study. BMC Cancer 2021;21:482.PMID: 33931014
Email
LinkedIn
Facebook
Twitter
Privacy Policy